Donald Staines: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
m (Text replacement - " \| ?last(.*)\=(.*)( *)\| ?first(.*)\=(.*)( *)\| ?author" to " |last$1=$2 |first$3$4 |author")
m (Undo revision 110574 by Notjusttired (talk))
Line 21: Line 21:
| last3  = Staines            | first3 = DR  | authorlink3 = Donald Staines
| last3  = Staines            | first3 = DR  | authorlink3 = Donald Staines
| last4  = Ashton            | first4 = KJ  | authorlink4 =
| last4  = Ashton            | first4 = KJ  | authorlink4 =
| last5  = Ramos              | first5 = SB  | authorlink5 = Sandra Ramos |last6  = Keane |first              6  |authorlink6 =   
| last5  = Ramos              | first5 = SB  | authorlink5 = Sandra Ramos
| last6  = Keane             | first6 = J    | authorlink6 =   
| last7  = Klimas            | first7 = NG  | authorlink7 = Nancy Klimas
| last7  = Klimas            | first7 = NG  | authorlink7 = Nancy Klimas
| last8  = Marshall-Gradisnik | first8 = SM  | authorlink8 = Sonya Marshall-Gradisnik
| last8  = Marshall-Gradisnik | first8 = SM  | authorlink8 = Sonya Marshall-Gradisnik
| title  = Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis|journal = Journal of Translational Medicine|volume =9|issue = 81|page =| date= 2011| doi= 10.1186/1479-5876-9-81}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120691/ (Full Text)]
| title  = Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis|journal = Journal of Translational Medicine|volume =9|issue = 81|page =| date= 2011| doi= 10.1186/1479-5876-9-81}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120691/ (Full Text)]
*2012, The Effects of [[Influenza vaccine|Influenza Vaccination]] on Immune Function in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis<ref>{{citation |last1  = Brenu |first              1  |authorlink1 = Ekua Brenu  
*2012, The Effects of [[Influenza vaccine|Influenza Vaccination]] on Immune Function in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis<ref>{{citation
| last1  = Brenu               | first1 = Ekua W    | authorlink1 = Ekua Brenu  
| last2  = van Driel          | first2 = Mieke L  | authorlink2 =  
| last2  = van Driel          | first2 = Mieke L  | authorlink2 =  
| last3  = Staines            | first3 = Donald R  | authorlink3 = Donald Staines
| last3  = Staines            | first3 = Donald R  | authorlink3 = Donald Staines
Line 100: Line 102:
==References==
==References==
<references>
<references>
<ref name="BrenuEW2014">{{citation |last1  = Brenu |first                1  |authorlink1 = Ekua Brenu |last2  = Huth |first                2  |authorlink2 = Teilah Huth |last3  = Hardcastle |first          3  |authorlink3 = Sharni Hardcastle |last4  = Fuller |first              4  |authorlink4 = |last5  = Kaur |first                5  |authorlink5 = |last6  = Johnston |first            6  |authorlink6 = Samantha Johnston |last7  = Ramos |first                7  |authorlink7 = Sandra Ramos |last8  = Staines |first              8  |authorlink8 = Donald Staines
<ref name="BrenuEW2014">{{citation
| last1  = Brenu               | first1 = EW      | authorlink1 = Ekua Brenu
| last2  = Huth                 | first2 = TK      | authorlink2 = Teilah Huth
| last3  = Hardcastle           | first3 = SL      | authorlink3 = Sharni Hardcastle
| last4  = Fuller               | first4 = K        | authorlink4 =  
| last5  = Kaur                 | first5 = M        | authorlink5 =  
| last6  = Johnston             | first6 = S        | authorlink6 = Samantha Johnston
| last7  = Ramos               | first7 = S        | authorlink7 = Sandra Ramos
| last8  = Staines             | first8 = D        | authorlink8 = Donald Staines
| last9  = Marshall-Gradisnik  | first9 = S        | authorlink9 = Sonya Marshall-Gradisnik
| last9  = Marshall-Gradisnik  | first9 = S        | authorlink9 = Sonya Marshall-Gradisnik
| title  = The Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis
| title  = The Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis
Line 106: Line 116:
| pmid    = 24343819 | doi = 10.1093/intimm/dxt068
| pmid    = 24343819 | doi = 10.1093/intimm/dxt068
}}</ref>
}}</ref>
<ref name="Collatz, 2016">{{Citation |last1= Collatz |first              1  |authorlink1 =  
<ref name="Collatz, 2016">{{Citation
|last2= Johnston | first2 = Samantha C.      | authorlink2 =Samantha Johnston |last3= Staines |first              3  |authorlink3 = Donald Staines
|last1= Collatz             | first1 = Ansel            | authorlink1 =  
|last2= Johnston | first2 = Samantha C.      | authorlink2 =Samantha Johnston  
|last3= Staines             | first3 = Donald R.        | authorlink3 = Donald Staines
|last4= Marshall-Gradisnik| first4 = Sonya M.        | authorlink4 = Sonya Marshall-Gradisnik
|last4= Marshall-Gradisnik| first4 = Sonya M.        | authorlink4 = Sonya Marshall-Gradisnik
|title  = A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
|title  = A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
Line 114: Line 126:
|pmid    = 27229907
|pmid    = 27229907
|doi    = 10.1016/j.clinthera.2016.04.038}}</ref>
|doi    = 10.1016/j.clinthera.2016.04.038}}</ref>
<ref name="Corbitt, 2018">{{Citation |last1  = Corbitt |first            1  |authorlink1 = |last2  = Campagnolo |first          2  |authorlink2 = |last3  = Staines |first            3  |authorlink3 = Donald Staines
<ref name="Corbitt, 2018">{{Citation
| last1  = Corbitt             | first1 = M            | authorlink1 =  
| last2  = Campagnolo         | first2 = N            | authorlink2 =  
| last3  = Staines             | first3 = D            | authorlink3 = Donald Staines
| last4  = Marshall-Gradisnik  | first4 = S            | authorlink4 = Sonya Marshall-Gradisnik  
| last4  = Marshall-Gradisnik  | first4 = S            | authorlink4 = Sonya Marshall-Gradisnik  
| title  = A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
| title  = A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
Line 123: Line 138:
}}
}}
</ref>
</ref>
<ref name="Eaton, 2018">{{citation |last1  = Eaton |first                1  |authorlink1 = |last2  = Cabanas |first              2  |authorlink2 = Hélène Cabanas |last3  = Balinas |first              3  |authorlink3 = |last4  = Klein |first                4  |authorlink4 = |last5  = Staines |first              5  |authorlink5 = Donald Staines
<ref name="Eaton, 2018">{{citation
| last1  = Eaton               | first1 = Natalie      | authorlink1 =  
| last2  = Cabanas             | first2 = Hélène      | authorlink2 = Hélène Cabanas
| last3  = Balinas             | first3 = Cassandra    | authorlink3 =  
| last4  = Klein               | first4 = Anne        | authorlink4 =  
| last5  = Staines             | first5 = Donald R.    | authorlink5 = Donald Staines
| last6  = Marshall-Gradisnik  | first6 = Sonya        | authorlink6 = Sonya Marshall-Gradisnik
| last6  = Marshall-Gradisnik  | first6 = Sonya        | authorlink6 = Sonya Marshall-Gradisnik
| title  = Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation
| title  = Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation
Line 132: Line 152:
| last1  = Hardcastle          | first1 = Sharni L. | authorlink1 = Sharni Hardcastle  
| last1  = Hardcastle          | first1 = Sharni L. | authorlink1 = Sharni Hardcastle  
| last2  = Brenu              | first2 = Ekua W.  | authorlink2 = Ekua Brenu
| last2  = Brenu              | first2 = Ekua W.  | authorlink2 = Ekua Brenu
| last3  = Johnston            | first3 = Samantha  | authorlink3 = Samantha Johnston |last4  = Nguyen |first              4  |authorlink4 =  
| last3  = Johnston            | first3 = Samantha  | authorlink3 = Samantha Johnston  
| last4  = Nguyen             | first4 = Thao      | authorlink4 =  
| last5  = Huth                | first5 = Teilah K. | authorlink5 = Teilah Huth
| last5  = Huth                | first5 = Teilah K. | authorlink5 = Teilah Huth
| last6  = Kaur                | first6 = Manprit  | authorlink6 = |last7  = Ramos |first              7  |authorlink7 = Sandra Ramos |last8  = Salajegheh |first          8  |authorlink8 =
| last6  = Kaur                | first6 = Manprit  | authorlink6 =  
| last7  = Ramos               | first7 = Sandra    | authorlink7 = Sandra Ramos
| last8  = Salajegheh         | first8 = Ali      | authorlink8 =
| last9  = Staines            | first9 = Donald R. | authorlink9 = Donald Staines
| last9  = Staines            | first9 = Donald R. | authorlink9 = Donald Staines
| last10  = Marshall-Gradisnik  | first10 = Sonya    | authorlink10 = Sonya Marshall-Gradisnik
| last10  = Marshall-Gradisnik  | first10 = Sonya    | authorlink10 = Sonya Marshall-Gradisnik
Line 144: Line 167:
}}
}}
</ref>
</ref>
<ref name="Hardcastle, 2015">{{Citation |last1  = Hardcastle |first            1  |authorlink1 = Sharni Hardcastle |last2  = Brenu |first                  2  |authorlink2 = Ekua Brenu |last3  = Johnston |first              3  |authorlink3 = Samantha Johnston |last4  = Nguyen |first                4  |authorlink4 = |last5  = Huth |first                  5  |authorlink5 = Teilah Huth |last6  = Wong |first                  6  |authorlink6 = |last7  = Ramos |first                  7  |authorlink7 = Sandra Ramos |last8  = Staines |first                8  |authorlink8 = Donald Staines |last9  = Marshall-Gradisnik |first    9  |authorlink9 = Sonya Marshall-Gradisnik
<ref name="Hardcastle, 2015">{{Citation
| last1  = Hardcastle             | first1 = SL      | authorlink1 = Sharni Hardcastle
| last2  = Brenu                 | first2 = EW      | authorlink2 = Ekua Brenu
| last3  = Johnston               | first3 = S      | authorlink3 = Samantha Johnston
| last4  = Nguyen                 | first4 = T      | authorlink4 =  
| last5  = Huth                   | first5 = T      | authorlink5 = Teilah Huth
| last6  = Wong                   | first6 = N      | authorlink6 =  
| last7  = Ramos                 | first7 = S      | authorlink7 = Sandra Ramos
| last8  = Staines               | first8 = DR      | authorlink8 = Donald Staines
| last9  = Marshall-Gradisnik     | first9 = SM      | authorlink9 = Sonya Marshall-Gradisnik
| title  = Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
| title  = Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
| journal = BMC Immunology    | volume = 16  | issue = 35  | page =  
| journal = BMC Immunology    | volume = 16  | issue = 35  | page =  
Line 154: Line 186:
| last1  = Hardcastle          | first1 = Sharni Lee | authorlink1 = Sharni Hardcastle
| last1  = Hardcastle          | first1 = Sharni Lee | authorlink1 = Sharni Hardcastle
| last2  = Brenu              | first2 = Ekua Weba  | authorlink2 = Ekua Brenu
| last2  = Brenu              | first2 = Ekua Weba  | authorlink2 = Ekua Brenu
| last3  = Johnston            | first3 = Samantha  | authorlink3 = Samantha Johnston |last4  = Nguyen |first              4  |authorlink4 = |last5  = Huth |first                5  |authorlink5 = Teilah Huth |last6  = Ramos |first              6  |authorlink6 = Sandra Ramos |last7  = Staines |first            7  |authorlink7 = Donald Staines
| last3  = Johnston            | first3 = Samantha  | authorlink3 = Samantha Johnston
| last4  = Nguyen             | first4 = Thao      | authorlink4 =  
| last5  = Huth               | first5 = Teilah    | authorlink5 = Teilah Huth
| last6  = Ramos               | first6 = Sandra    | authorlink6 = Sandra Ramos
| last7  = Staines             | first7 = Donald    | authorlink7 = Donald Staines
| last8  = Marshall-Gradisnik  | first8 = Sonya      | authorlink8 = Sonya Marshall-Gradisnik
| last8  = Marshall-Gradisnik  | first8 = Sonya      | authorlink8 = Sonya Marshall-Gradisnik
| title  = Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
| title  = Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
Line 162: Line 198:
}}
}}
</ref>
</ref>
<ref name="Hardcastle, 09052015">{{Citation |last1  = Hardcastle |first            1  |authorlink1 = Sharni Hardcastle |last2  = Brenu |first                2  |authorlink2 = Ekua Brenu |last3  = Johnston |first              3  |authorlink3 = Samantha Johnston |last4  = Nguyen |first                4  |authorlink4 = |last5  = Huth |first                  5  |authorlink5 = Teilah Huth |last6  = Wong |first                  6  |authorlink6 = |last7  = Ramos |first                 |authorlink7 = Sandra Ramos |last8  = Staines |first              8  |authorlink8 = Donald Staines |last9  = Marshall-Gradisnik |first    9  |authorlink9 = Sonya Marshall-Gradisnik  
<ref name="Hardcastle, 09052015">{{Citation
| last1  = Hardcastle           | first1 = SL                | authorlink1 = Sharni Hardcastle
| last2  = Brenu                 | first2 = EW                | authorlink2 = Ekua Brenu
| last3  = Johnston             | first3 = S                | authorlink3 = Samantha Johnston
| last4  = Nguyen               | first4 = T                | authorlink4 =  
| last5  = Huth                 | first5 = T                | authorlink5 = Teilah Huth
| last6  = Wong                 | first6 = N                | authorlink6 =  
| last7  = Ramos                 | first7 = S                 | authorlink7 = Sandra Ramos
| last8  = Staines               | first8 = DR                | authorlink8 = Donald Staines
| last9  = Marshall-Gradisnik   | first9 = SM                | authorlink9 = Sonya Marshall-Gradisnik  
| title  = Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
| title  = Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
| journal = International Journal of Medical Sciences    | volume = 12  | issue = 10  | page = 764-772
| journal = International Journal of Medical Sciences    | volume = 12  | issue = 10  | page = 764-772
Line 170: Line 215:
</ref>
</ref>
<ref name="Huth, 2014">{{Citation
<ref name="Huth, 2014">{{Citation
| last1  = Huth                | first1 = Teilah K.  | authorlink1 = Teilah Huth |last2  = Brenu |first              2  |authorlink2 = Ekua Brenu |last3  = Nguyen |first              3  |authorlink3 =  
| last1  = Huth                | first1 = Teilah K.  | authorlink1 = Teilah Huth
| last2  = Brenu               | first2 = Ekua      | authorlink2 = Ekua Brenu
| last3  = Nguyen             | first3 = Thao      | authorlink3 =  
| last4  = Hardcastle          | first4 = Sharni L.  | authorlink4 = Sharni Hardcastle
| last4  = Hardcastle          | first4 = Sharni L.  | authorlink4 = Sharni Hardcastle
| last5  = Johnston            | first5 = Samantha  | authorlink5 = Samantha Johnston |last6  = Ramos |first              6  |authorlink6 = Sandra Ramos
| last5  = Johnston            | first5 = Samantha  | authorlink5 = Samantha Johnston
| last6  = Ramos               | first6 = Sandra    | authorlink6 = Sandra Ramos
| last7  = Staines            | first7 = Donald R.  | authorlink7 = Donald Staines
| last7  = Staines            | first7 = Donald R.  | authorlink7 = Donald Staines
| last8  = Marshall-Gradisnik  | first8 = Sonya M.  | authorlink8 = Sonya Marshall-Gradisnik
| last8  = Marshall-Gradisnik  | first8 = Sonya M.  | authorlink8 = Sonya Marshall-Gradisnik
Line 183: Line 231:
</ref>
</ref>
<ref name="Huth, 2016">{{Citation
<ref name="Huth, 2016">{{Citation
| last1  = Huth                | first1 = Teilah K.  | authorlink1 = Teilah Huth |last2  = Staines |first            2  |authorlink2 = Donald Staines
| last1  = Huth                | first1 = Teilah K.  | authorlink1 = Teilah Huth
| last2  = Staines             | first2 = Donald    | authorlink2 = Donald Staines
| last3  = Marshall-Gradisnik  | first3 = Sonya      | authorlink3 = Sonya Marshall-Gradisnik
| last3  = Marshall-Gradisnik  | first3 = Sonya      | authorlink3 = Sonya Marshall-Gradisnik
| title  = ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
| title  = ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
Line 192: Line 241:
}}
}}
</ref>
</ref>
<ref name="Huth,TK, 2016">{{Citation |last1  = Huth |first                1  |authorlink1 = Teilah Huth |last2  = Brenu |first                2  |authorlink2 = Ekua Brenu |last3  = Staines |first              3  |authorlink3 = Donald Staines
<ref name="Huth,TK, 2016">{{Citation
| last1  = Huth                 | first1 = T.K.    | authorlink1 = Teilah Huth
| last2  = Brenu               | first2 = E.W.    | authorlink2 = Ekua Brenu
| last3  = Staines             | first3 = D.R.    | authorlink3 = Donald Staines
| last4  = Marshall-Gradisnik  | first4 = S.M.    | authorlink4 = Sonya Marshall-Gradisnik
| last4  = Marshall-Gradisnik  | first4 = S.M.    | authorlink4 = Sonya Marshall-Gradisnik
| title  = Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
| title  = Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
Line 201: Line 253:
}}
}}
</ref>
</ref>
<ref name="Marshall-Gradisnik, 2015">{{Citation |last1  = Marshall-Gradisnik |first    1  |authorlink1 =  Sonya Marshall-Gradisnik |last2  = Smith |first                  2  |authorlink2 = |last3  = Brenu |first                  3  |authorlink3 = Ekua Brenu |last4  = Nilius |first                4  |authorlink4 = |last5  = Ramos |first                  5  |authorlink5 = |last6  = Staines |first                6  |authorlink6 = Donald Staines  
<ref name="Marshall-Gradisnik, 2015">{{Citation
| last1  = Marshall-Gradisnik     | first1 = Sonya M.      | authorlink1 =  Sonya Marshall-Gradisnik
| last2  = Smith                 | first2 = Peter          | authorlink2 =  
| last3  = Brenu                 | first3 = Ekua W.        | authorlink3 = Ekua Brenu
| last4  = Nilius                 | first4 = Bernd          | authorlink4 =  
| last5  = Ramos                 | first5 = Sandra B.      | authorlink5 =  
| last6  = Staines               | first6 = Donald R.      | authorlink6 = Donald Staines  
| title  = Examination of Single Nucleotide Polymorphisms (SNPs) in Transient Receptor Potential (TRP) Ion Channels in Chronic Fatigue Syndrome Patients
| title  = Examination of Single Nucleotide Polymorphisms (SNPs) in Transient Receptor Potential (TRP) Ion Channels in Chronic Fatigue Syndrome Patients
| journal = Immunology and Immunogenetics Insights    | volume = 2015  | issue = 7  | page = 1-6
| journal = Immunology and Immunogenetics Insights    | volume = 2015  | issue = 7  | page = 1-6
Line 210: Line 268:
}}
}}
</ref>
</ref>
<ref name="Marshall-Gradisnik,SM 2016">{{Citation |last1  = Marshall-Gradisnik |first    1  |authorlink1 =Sonya Marshall-Gradisnik |last2  = Huth |first                  2  |authorlink2 = Teilah Huth |last3  = Chacko |first                3  |authorlink3 = Ekua Brenu |last4  = Johnston |first              4  |authorlink4 = Samantha Johnston |last5  = Smith |first                5  |authorlink5 = |last6  = Staines |first              6  |authorlink6 = Donald Staines  
<ref name="Marshall-Gradisnik,SM 2016">{{Citation
| last1  = Marshall-Gradisnik   | first1 = Sonya M.        | authorlink1 =Sonya Marshall-Gradisnik
| last2  = Huth                 | first2 = Teilah          | authorlink2 = Teilah Huth
| last3  = Chacko               | first3 = Anu            | authorlink3 = Ekua Brenu
| last4  = Johnston             | first4 = Samantha        | authorlink4 = Samantha Johnston
| last5  = Smith                 | first5 = Peter          | authorlink5 =  
| last6  = Staines               | first6 = Donald R.      | authorlink6 = Donald Staines  
| title  = Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome
| title  = Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome
| journal =  The Application of Clinical Genetics  | volume = 9  | issue =  | page = 39—47  
| journal =  The Application of Clinical Genetics  | volume = 9  | issue =  | page = 39—47  
Line 218: Line 282:
}}
}}
</ref>
</ref>
<ref name="Nguyen, 2017">{{Citation |last1  = Nguyen |first              1  |authorlink1 = |last2  = Hardcastle |first          2  |authorlink2 = Sharni Hardcastle |last3  = Clarke |first              3  |authorlink3 = |last4  = Smith |first                4  |authorlink4 =   |last5  = Staines |first              5  |authorlink5 = Donald Staines
<ref name="Nguyen, 2017">{{Citation
| last1  = Nguyen               | first1 = T.      | authorlink1 =  
| last2  = Hardcastle           | first2 = S.      | authorlink2 = Sharni Hardcastle
| last3  = Clarke               | first3 = L.      | authorlink3 =  
| last4  = Smith               | first4 = P.      | authorlink4 =  
| last5  = Staines             | first5 = D.      | authorlink5 = Donald Staines
| last6  = Marshall-Gradisnik  | first6 = S.      | authorlink6 = Sonya Marshall-Gradisnik
| last6  = Marshall-Gradisnik  | first6 = S.      | authorlink6 = Sonya Marshall-Gradisnik
| title  = Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels
| title  = Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels
Line 226: Line 295:
}}
}}
</ref>
</ref>
<ref name="Peterson, 2015">{{Citation |last1  = Peterson |first                1  |authorlink1 = Daniel Peterson |last2  = Brenu |first                    2  |authorlink2 = Ekua Brenu |last3  = Gottschalk |first              3  |authorlink3 = Gunnar Gottschalk |last4  = Ramos |first                    4  |authorlink4 = Sandra Ramos |last5  = Nguyen |first                  5  |authorlink5 = |last6  = Staines |first                  6  |authorlink6 = Donald Staines |last7  = Marshall-Gradisnik |first      7  |authorlink7 = Sonya Marshall-Gradisnik
<ref name="Peterson, 2015">{{Citation
| last1  = Peterson                 | first1 = D            | authorlink1 = Daniel Peterson
| last2  = Brenu                   | first2 = EW            | authorlink2 = Ekua Brenu
| last3  = Gottschalk               | first3 = G            | authorlink3 = Gunnar Gottschalk
| last4  = Ramos                   | first4 = Sandra B      | authorlink4 = Sandra Ramos  
| last5  = Nguyen                   | first5 = T            | authorlink5 =  
| last6  = Staines                 | first6 = D            | authorlink6 = Donald Staines
| last7  = Marshall-Gradisnik       | first7 = S            | authorlink7 = Sonya Marshall-Gradisnik
| title  = Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
| title  = Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
| journal = Mediators of Inflammation    | volume = 2015  | issue =    | page =  
| journal = Mediators of Inflammation    | volume = 2015  | issue =    | page =  
Line 233: Line 309:
}}
}}
</ref>
</ref>
<ref name="Ramos, 2016">{{Citation |last1  = Ramos |first                1  |authorlink1 = Sandra Ramos |last2  = Brenu |first                2  |authorlink2 = Ekua Brenu |last3  = Broadley |first              3  |authorlink3 = |last4  = Kwiatek |first              4  |authorlink4 = Richard Kwiatek |last5  = Ng |first                    5  |authorlink5 = |last6  = Nguyen |first                6  |authorlink6 = |last7  = Freeman |first              7  |authorlink7 = |last8  = Staines |first              8  |authorlink8 = Donald Staines   |last9  = Marshall-Gradisnik |first    9  |authorlink9 = Sonya Marshall-Gradisnik
<ref name="Ramos, 2016">{{Citation
| last1  = Ramos                 | first1 = S      | authorlink1 = Sandra Ramos
| last2  = Brenu                 | first2 = E      | authorlink2 = Ekua Brenu
| last3  = Broadley             | first3 = S      | authorlink3 =  
| last4  = Kwiatek               | first4 = R      | authorlink4 = Richard Kwiatek
| last5  = Ng                   | first5 = J      | authorlink5 =  
| last6  = Nguyen               | first6 = T      | authorlink6 =  
| last7  = Freeman               | first7 = S      | authorlink7 =  
| last8  = Staines               | first8 = D      | authorlink8 = Donald Staines
| last9  = Marshall-Gradisnik   | first9 = S      | authorlink9 = Sonya Marshall-Gradisnik
| title  = Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison
| title  = Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison
| journal = Asian Pac J Allergy Immunol    | volume =    | issue =    | page =  
| journal = Asian Pac J Allergy Immunol    | volume =    | issue =    | page =  
Line 240: Line 325:
}}
}}
</ref>
</ref>
<ref name="Shan, 2016">{{Citation |last1  = Shan |first                  1 |authorlink1 =Zack Shan |last2  = Kwiatek |first                2 |authorlink2 = Richard Kwiatek |last3  = Burnet |first                3 |authorlink3 =Richard Burnet |last4  = Del Fante |first              4 |authorlink4 =Peter Del Fante |last5  = Staines |first                5 |authorlink5 = Donald Staines |last6  = Marshall‐Gradisnik |first    6  |authorlink6 = Sonya Marshall-Gradisnik |last7  = Barnden |first                7 |authorlink7 =Leighton Barnden  
<ref name="Shan, 2016">{{Citation
| last1  = Shan                   | first1 = Zack Y.        | authorlink1 =Zack Shan  
| last2  = Kwiatek               | first2 = Richard        | authorlink2 = Richard Kwiatek
| last3  = Burnet                 | first3 = Richard        | authorlink3 =Richard Burnet  
| last4  = Del Fante             | first4 = Peter          | authorlink4 =Peter Del Fante  
| last5  = Staines               | first5 = Donald R.      | authorlink5 = Donald Staines
| last6  = Marshall‐Gradisnik     | first6 = Sonya          | authorlink6 = Sonya Marshall-Gradisnik
| last7  = Barnden               | first7 = Leighton R.    | authorlink7 =Leighton Barnden  
| title  = Progressive brain changes in patients with chronic fatigue syndrome: A longitudinal MRI study
| title  = Progressive brain changes in patients with chronic fatigue syndrome: A longitudinal MRI study
| journal =  Journal of Magnetic Resonance Imaging    | volume = 44  | issue =    | page = 1301–1311
| journal =  Journal of Magnetic Resonance Imaging    | volume = 44  | issue =    | page = 1301–1311
Line 248: Line 340:
}}
}}
</ref>
</ref>
<ref name="Shan, 2018">{{Citation |last1  = Shan |first                  1 |authorlink1 = |last2  = Finegan |first                2 |authorlink2 = |last3  = Bhuta |first                  3 |authorlink3 = |last4  = Ireland |first                4 |authorlink4 = |last5  = Staines |first                5 |authorlink5 = Donald Staines |last6  = Marshall‐Gradisnik |first    6 |authorlink6 = Sonya Marshall-Gradisnik |last7  = Barnden |first                7 |authorlink7 =  
<ref name="Shan, 2018">{{Citation
| last1  = Shan                   | first1 = Zack Y.        | authorlink1 =  
| last2  = Finegan               | first2 = Kevin          | authorlink2 =  
| last3  = Bhuta                 | first3 = Sandeep        | authorlink3 =  
| last4  = Ireland               | first4 = Timothy        | authorlink4 =  
| last5  = Staines               | first5 = Donald R.      | authorlink5 = Donald Staines
| last6  = Marshall‐Gradisnik     | first6 = Sonya          | authorlink6 = Sonya Marshall-Gradisnik
| last7  = Barnden               | first7 = Leighton R.    | authorlink7 =  
| title  = Brain function characteristics of [[chronic fatigue syndrome]]: A task fMRI study
| title  = Brain function characteristics of [[chronic fatigue syndrome]]: A task fMRI study
| journal = NeuroImage: Clinical  | volume = 19  | issue =    | page = 279-286
| journal = NeuroImage: Clinical  | volume = 19  | issue =    | page = 279-286
Line 256: Line 355:
}}
}}
</ref>
</ref>
<ref name="Wong, 2015">{{Citation |last1  = Wong |first                1  |authorlink1 = |last2  = Nguyen |first              2  |authorlink2 =  
<ref name="Wong, 2015">{{Citation
| last3  = Brenu              | first3 = Ekua Weba  | authorlink3 = Ekua Brenu |last4  = Broadley |first            4  |authorlink4 = |last5  = Staines |first            5  |authorlink5 = Donald Staines
| last1  = Wong               | first1 = Naomi      | authorlink1 =  
| last2  = Nguyen             | first2 = Thao      | authorlink2 =  
| last3  = Brenu              | first3 = Ekua Weba  | authorlink3 = Ekua Brenu
| last4  = Broadley           | first4 = Simon      | authorlink4 =  
| last5  = Staines             | first5 = Donald    | authorlink5 = Donald Staines
| last6  = Marshall-Gradisnik  | first6 = Sonya      | authorlink6 = Sonya Marshall-Gradisnik
| last6  = Marshall-Gradisnik  | first6 = Sonya      | authorlink6 = Sonya Marshall-Gradisnik
| title  = A Comparison of Cytokine Profiles of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis Patients
| title  = A Comparison of Cytokine Profiles of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis Patients

Revision as of 20:47, May 11, 2022

Source: investinme.org

Professor Donald R. Staines, MBBS, MPH, FAFPHM, FAFOEM, is a Clinical Professor at Menzies Health Institute Queensland and the co-director (alongside Sonya Marshall-Gradisnik) of the National Centre for Neuroimmunology and Emerging Diseases (NCNED) at Griffith University in Queensland in north-eastern Australia.[1] His research team is working towards discovery of diagnostic tools and treatments for chronic fatigue syndrome.[2]

International Consensus Criteria[edit | edit source]

Staines is one of the authors of the 2011 case definition, International Consensus Criteria.[3]

Diagnostic test[edit | edit source]

In February 2016 the research team led by Donald Staines and Sonya Marshall-Gradisnik announced it had created a diagnostic test for the disease using CD8 T cells.[4] They have been awarded a $4-million grant to be administered during the next five years that will enable them to continue research into developing a diagnostic test for ME/CFS.[5]

Open Letters to The Lancet[edit | edit source]

Three open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Staines, along with 41 colleagues in the ME/CFS field, signed the second letter. In June 2018, Dr. Staines signed the third letter, this time along with approximately 100 colleagues.

Notable studies[edit | edit source]

  • 2011, Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[6] - (Full Text)
  • 2012, The Effects of Influenza Vaccination on Immune Function in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[7] - (Full Text)
  • 2014, Characterization of Natural Killer Cell Phenotypes in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[8] - (Full Text)
  • 2014, The Role of Adaptive and Innate Immune Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[9] - (Full Text)
  • 2014, The role of clinical guidelines for chronic fatigue syndrome/myalgic encephalomyelitis in research settings[10] - (Abstract)
  • 2014, Analysis of the Relationship between Immune Dysfunction and Symptom Severity in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)[11] - (Full Text)
  • 2015, A Comparison of Cytokine Profiles of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis Patients[12]
  • 2015, Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients[13] - (Abstract)
  • 2015, Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients[14] - (Full Text)
  • 2015, Examination of Single Nucleotide Polymorphisms (SNPs) in Transient Receptor Potential (TRP) Ion Channels in Chronic Fatigue Syndrome Patients[15] - (Full Text)
  • 2015, Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)[16] - (Full Text)
  • 2015, Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients[17] - (Full Text)
  • 2015, Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[18]
  • 2016, Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients[19] - (Full Text)
  • 2016, A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[20] -(Abstract)
  • 2016, Progressive brain changes in patients with chronic fatigue syndrome: A longitudinal MRI study[21] - (Full Text)
  • 2016, Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison[22] - (Full Text)
  • 2016, ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients[23] - (Full Text)
  • 2016, Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome[24] - (Full Text)
  • 2017, Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review[25] - (Full Text)
  • 2017, Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels[26] - (Full Text)
  • 2017, Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients[27] - (Full Text)
  • 2018, Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[28] - (Full text)
  • 2018, Brain function characteristics of chronic fatigue syndrome: A task fMRI study[29] - (Full Text)
  • 2018, A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)[30] - (Abstract)
  • 2018, A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis[31] - (Full text)
  • 2018, Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation[32] - (Full Text)
  • 2018, Reduced glycolytic reserve in isolated natural killer cells from Myalgic encephalomyelitis/chronic fatigue syndrome patients: A preliminary investigation[33] - (Abstract)
  • 2018, Hyperintense sensorimotor T1 spin echo MRI is associated with brainstem abnormality in chronic fatigue syndrome[34] - (Full Text)
  • 2018, Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients[35] - (Full Text)
  • 2019, Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study[36] - (Full text)
  • 2019, Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients[37] - (Full text)
  • 2019, A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID)[38] - (Full text)
  • 2019, Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients[39] - (Abstract)
  • 2019, Intra brainstem connectivity is impaired in chronic fatigue syndrome[40] - (Full text)
  • 2019, Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients[41] - (Full text)
  • 2020, Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study[42] - (Full text)
  • 2020, Mapping of pathological change in chronic fatigue syndrome using the ratio of T1- and T2-weighted MRI scans[43] - (Full text)
  • 2021, Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[44] (Full text)

Talks and interviews[edit | edit source]

Learn more[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. "National Centre for Neuroimmunology and Emerging Diseases". www.griffith.edu.au. Retrieved November 14, 2019.
  2. "Coast team zeroing in on CFS test". www.goldcoastbulletin.com.au. December 1, 2016. Retrieved April 26, 2019.
  3. Carruthers, Bruce M.; van de Sande, Marjorie I.; De Meirleir, Kenny L.; Klimas, Nancy G.; Broderick, Gordon; Mitchell, Terry; Staines, Donald; Powles, A. C. Peter; Speight, Nigel; Vallings, Rosamund; Bateman, Lucinda; Baumgarten-Austrheim, Barbara; Bell, David; Carlo-Stella, Nicoletta; Chia, John; Darragh, Austin; Jo, Daehyun; Lewis, Donald; Light, Alan; Marshall-Gradisnik, Sonya; Mena, Ismael; Mikovits, Judy; Miwa, Kunihisa; Murovska, Modra; Pall, Martin; Stevens, Staci (August 22, 2011). "Myalgic encephalomyelitis: International Consensus Criteria". Journal of Internal Medicine. 270 (4): 327–338. doi:10.1111/j.1365-2796.2011.02428.x. ISSN 0954-6820. PMC 3427890. PMID 21777306.
  4. Australian scientists make breakthrough in Chronic Fatigue Syndrome testing, ABC News (Australia), 29 February 2016
  5. "Coast team zeroing in on CFS test". www.goldcoastbulletin.com.au. December 1, 2016. Retrieved April 26, 2019.
  6. Brenu, EW; van Driel, ML; Staines, DR; Ashton, KJ; Ramos, SB; Keane, J; Klimas, NG; Marshall-Gradisnik, SM (2011), "Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Journal of Translational Medicine, 9 (81), doi:10.1186/1479-5876-9-81
  7. Brenu, Ekua W; van Driel, Mieke L; Staines, Donald R; Kreijkamp-Kaspers, Sanne; Hardcastle, Sharni L; Marshall-Gradisnik, Sonya M (2012), "The Effects of Influenza Vaccination on Immune Function in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis" (PDF), International Journal of Clinical Medicine, 3 (6): 544-551, doi:10.4236/ijcm.2012.36098
  8. Huth, Teilah K.; Brenu, Ekua; Nguyen, Thao; Hardcastle, Sharni L.; Johnston, Samantha; Ramos, Sandra; Staines, Donald R.; Marshall-Gradisnik, Sonya M. (2014), "Characterization of Natural Killer Cell Phenotypes in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Journal of Clinical & Cellular Immunology, 5 (3), doi:10.4172/2155-9899.1000223
  9. Brenu, EW; Huth, TK; Hardcastle, SL; Fuller, K; Kaur, M; Johnston, S; Ramos, S; Staines, D; Marshall-Gradisnik, S (2014), "The Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis", International Immunology, 26 (4): 233-42, doi:10.1093/intimm/dxt068, PMID 24343819
  10. Johnston, S.C.; Brenu, E.W.; Staines, D.R.; Marshall-Gradisnik, S.M. (January 2, 2014). "The role of clinical guidelines for chronic fatigue syndrome/myalgic encephalomyelitis in research settings". Fatigue: Biomedicine, Health & Behavior. 2 (1): 28–39. doi:10.1080/21641846.2013.860779. ISSN 2164-1846.
  11. Hardcastle, Sharni L.; Brenu, Ekua W.; Johnston, Samantha; Nguyen, Thao; Huth, Teilah K.; Kaur, Manprit; Ramos, Sandra; Salajegheh, Ali; Staines, Donald R.; Marshall-Gradisnik, Sonya (2014), "Analysis of the Relationship between Immune Dysfunction and Symptom Severity in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)", Journal of Clinical & Cellular Immunology, 5 (190), doi:10.4172/2155-9899.1000190
  12. Wong, Naomi; Nguyen, Thao; Brenu, Ekua Weba; Broadley, Simon; Staines, Donald; Marshall-Gradisnik, Sonya (2015), "A Comparison of Cytokine Profiles of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis Patients", International Journal of Clinical Medicine, 6 (10): 769-783, doi:10.4236/ijcm.2015.610103
  13. Armstrong, Christopher W.; McGregor, Neil R.; Lewis, Donald P.; Butt, Henry L.; Gooley, Paul R. (2015), "Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients", Metabolomics, 11 (6): 1626–1639, doi:10.1007/s11306-015-0816-5
  14. Hardcastle, SL; Brenu, EW; Johnston, S; Nguyen, T; Huth, T; Wong, N; Ramos, S; Staines, DR; Marshall-Gradisnik, SM (2015), "Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients", International Journal of Medical Sciences, 12 (10): 764-772, doi:10.7150/ijms.12399
  15. Marshall-Gradisnik, Sonya M.; Smith, Peter; Brenu, Ekua W.; Nilius, Bernd; Ramos, Sandra B.; Staines, Donald R. (2015), "Examination of Single Nucleotide Polymorphisms (SNPs) in Transient Receptor Potential (TRP) Ion Channels in Chronic Fatigue Syndrome Patients", Immunology and Immunogenetics Insights, 2015 (7): 1-6, doi:10.4137/III.S25147
  16. Hardcastle, SL; Brenu, EW; Johnston, S; Nguyen, T; Huth, T; Wong, N; Ramos, S; Staines, DR; Marshall-Gradisnik, SM (2015), "Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)", BMC Immunology, 16 (35), doi:10.1186/s12865-015-0101-4
  17. Hardcastle, Sharni Lee; Brenu, Ekua Weba; Johnston, Samantha; Nguyen, Thao; Huth, Teilah; Ramos, Sandra; Staines, Donald; Marshall-Gradisnik, Sonya (2015), "Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients", Journal of Translational Medicine, 13 (299), doi:10.1186/s12967-015-0653-3
  18. Peterson, D; Brenu, EW; Gottschalk, G; Ramos, Sandra B; Nguyen, T; Staines, D; Marshall-Gradisnik, S (2015), "Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Mediators of Inflammation, 2015, doi:10.1155/2015/929720
  19. Huth, T.K.; Brenu, E.W.; Staines, D.R.; Marshall-Gradisnik, S.M. (2016), "Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients", Gene Regulation and Systems Biology, 10: 43–49, doi:10.4137/GRSB.S39861
  20. Collatz, Ansel; Johnston, Samantha C.; Staines, Donald R.; Marshall-Gradisnik, Sonya M. (2016), "A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Clinical Therapeutics, 38 (6): 1263-1271.e9, doi:10.1016/j.clinthera.2016.04.038, PMID 27229907
  21. Shan, Zack Y.; Kwiatek, Richard; Burnet, Richard; Del Fante, Peter; Staines, Donald R.; Marshall‐Gradisnik, Sonya; Barnden, Leighton R. (2016), "Progressive brain changes in patients with chronic fatigue syndrome: A longitudinal MRI study", Journal of Magnetic Resonance Imaging, 44: 1301–1311, doi:10.1002/jmri.25283
  22. Ramos, S; Brenu, E; Broadley, S; Kwiatek, R; Ng, J; Nguyen, T; Freeman, S; Staines, D; Marshall-Gradisnik, S (March 20, 2016), "Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison", Asian Pac J Allergy Immunol, doi:10.12932/AP0733
  23. Huth, Teilah K.; Staines, Donald; Marshall-Gradisnik, Sonya (2016), "ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients", Journal of Translational Medicine, 14 (97), doi:10.1186/s12967-016-0859-z
  24. Marshall-Gradisnik, Sonya M.; Huth, Teilah; Chacko, Anu; Johnston, Samantha; Smith, Peter; Staines, Donald R. (2016), "Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome", The Application of Clinical Genetics, 9: 39—47, doi:10.2147/TACG.S99405
  25. Campagnolo, N.; Johnston, S.; Collatz, A.; Staines, D.; Marshall-Gradisnik, S. (January 22, 2017). "Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review". Journal of Human Nutrition and Dietetics. 30 (3): 247–259. doi:10.1111/jhn.12435. ISSN 0952-3871. PMID 28111818.
  26. Nguyen, T.; Hardcastle, S.; Clarke, L.; Smith, P.; Staines, D.; Marshall-Gradisnik, S. (2017), "Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels", Clinical and Experimental Immunology, 187 (2): 284–293, doi:10.1111/cei.12882
  27. Nguyen, T.; Johnston, S.; Chacko, A.; Gibson, D.; Cepon, J.; Smith, D.; Staines, D.; Marshall-Gradisnik, S. (2017), "Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients", Asian Pac J Allergy Immunol, 35 (2): 75-81, doi:10.12932/AP0771
  28. Marshall-Gradisnik, Sonya; Fretel, Marshall; Eaton, Natalie; Cabanas, Helene; Balinas, Cassandra; Gopalan, Vinod; Petersen, Daniel; Passmore, Rachel; Tang, Kevin; Haque, Mazhar; Lam, Alfred; Staines, Donald (May 31, 2018). "Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis". International Journal of Clinical Medicine. 09 (05): 467. doi:10.4236/ijcm.2018.95040.
  29. Shan, Zack Y.; Finegan, Kevin; Bhuta, Sandeep; Ireland, Timothy; Staines, Donald R.; Marshall‐Gradisnik, Sonya; Barnden, Leighton R. (2018), "Brain function characteristics of chronic fatigue syndrome: A task fMRI study", NeuroImage: Clinical, 19: 279-286, doi:10.1016/j.nicl.2018.04.025
  30. Corbitt, M; Campagnolo, N; Staines, D; Marshall-Gradisnik, S (2018), "A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)", Probiotics Antimicrob Proteins, doi:10.1007/s12602-018-9397-8
  31. Du Preez, S.; Corbitt, M.; Cabanas, H.; Eaton, N.; Staines, D.; Marshall-Gradisnik, S. (December 20, 2018). "A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis". Systematic Reviews. 7 (1): 241. doi:10.1186/s13643-018-0909-0. ISSN 2046-4053. PMID 30572962.
  32. Eaton, Natalie; Cabanas, Hélène; Balinas, Cassandra; Klein, Anne; Staines, Donald R.; Marshall-Gradisnik, Sonya (2018), "Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation", BMC Pharmacology & Toxicology, 19 (12), doi:10.1186/s40360-018-0203-8, PMID 29587879
  33. Nguyen, T.; Staines, D.; Johnston, S.; Marshall-Gradisnik, S. (July 2018), "Reduced glycolytic reserve in isolated natural killer cells from Myalgic encephalomyelitis/chronic fatigue syndrome patients: A preliminary investigation", Asian Pac J Allergy Immunol, doi:10.12932/AP-011117-0188
  34. Barnden, Leighton R.; Shan, Zack Y.; Staines, Donald R.; Marshall-Gradisnik, Sonya; Finegan, Kevin; Ireland, Timothy; Bhuta, Sandeep (2018). "Hyperintense sensorimotor T1 spin echo MRI is associated with brainstem abnormality in chronic fatigue syndrome". NeuroImage: Clinical. 20: 102–109. doi:10.1016/j.nicl.2018.07.011.
  35. Cabanas, Hélène; Muraki, Katsuhiko; Eaton, Natalie; Balinas, Cassandra; Staines, Donald; Marshall-Gradisnik, Sonya (August 14, 2018). "Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients". Molecular Medicine. 24 (1). doi:10.1186/s10020-018-0046-1. ISSN 1076-1551.
  36. Słomko, Joanna; Newton, Julia L; Kujawski, Sławomir; Tafil-Klawe, Małgorzata; Klawe, Jacek; Staines, Donald; Marshall-Gradisnik, Sonya; Zalewski, Pawel (March 2019). "Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study". BMJ Open. 9 (3): e023955. doi:10.1136/bmjopen-2018-023955. ISSN 2044-6055. PMID 30850404.
  37. Cabanas, H.; Muraki, K.; Balinas, C.; Eaton-Fitch, N.; Staines, D.; Marshall-Gradisnik, S. (December 2019). "Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients". Molecular Medicine. 25 (1). doi:10.1186/s10020-019-0083-4. ISSN 1076-1551.
  38. Corbitt, Matthew; Eaton-Fitch, Natalie; Staines, Donald; Cabanas, Hélène; Marshall-Gradisnik, Sonya (December 2019). "A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID)". BMC Neurology. 19 (1). doi:10.1186/s12883-019-1433-0. ISSN 1471-2377. PMID 31445522.
  39. Cabanas, Helene; Muraki, Katsuhiko; Staines, Donald; Marshall-Gradisnik, Sonya (October 14, 2019). "Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients". Frontiers in Immunology. doi:10.3389/fimmu.2019.02545.
  40. Barnden, Leighton R; Shan, Zack Y; Staines, Donald R; Marshall-Gradisnik, Sonya; Finegan, Kevin; Ireland, Timothy; Bhuta, Sandeep (2019). "Intra brainstem connectivity is impaired in chronic fatigue syndrome". NeuroImage: Clinical. 24: 102045. doi:10.1016/j.nicl.2019.102045.
  41. Balinas, Cassandra; Cabanas, Hélène; Staines, Donald; Marshall-Gradisnik, Sonya (December 3, 2019). "Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients". Journal of Translational Medicine. 17 (1): 401. doi:10.1186/s12967-019-02155-4. ISSN 1479-5876. PMC 6891975. PMID 31796045.
  42. Eaton-Fitch, N.; Johnston, S. C.; Zalewski, P.; Staines, D.; Marshall-Gradisnik, S. (January 22, 2020). "Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study". Quality of Life Research. doi:10.1007/s11136-019-02411-6. ISSN 0962-9343.
  43. Thapaliya, Kiran; Marshall-Gradisnik, Sonya; Staines, Don; Barnden, Leighton (2020). "Mapping of pathological change in chronic fatigue syndrome using the ratio of T1- and T2-weighted MRI scans". NeuroImage: Clinical. 28: 102366. doi:10.1016/j.nicl.2020.102366. PMC 7417892. PMID 32777701.
  44. Maksoud, Rebekah; Eaton-Fitch, Natalie; Matula, Michael; Cabanas, Hélène; Staines, Donald; Marshall-Gradisnik, Sonya (May 2021). "Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Healthcare. 9 (5): 568. doi:10.3390/healthcare9050568.
  45. 45.0 45.1 "Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved April 26, 2019.
  46. "Invest in ME Research - IIMEC14 14th Invest in ME Reseaerch International ME Conference 2019". Invest in ME Research. Retrieved February 26, 2020.